Latest Trials

EudraCT Number: 2005-003093-21

Sponsor Protocol Number: 20091977

Start Date:

Sponsor Name: Medical Department I

Full Title: Influence of combined therapy of niacin and statins on stem cell mobilization and inflammatory parameters in patients suffering from coronary artery disease – randomized clinical study -

Medical condition: Have stable coronary artery disease (i.e. no acute event like myocardial infarction or PTCA less then 3 months ago)

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: (No results available)

EudraCT Number: 2007-002223-32

Sponsor Protocol Number: E2007-0507

Start Date:

Sponsor Name: Charité Universitaetsmedizin

Full Title: A multicentre, double-blind, randomised placebo-controlled trial of sodium bicarbonate to prevent acute kidney injury in patients undergoing cardiopulmonary bypass surgery.

Medical condition: Cardiac surgical patients in whom the use of cardiopulmonary bypass is planned and having at least one ore more of the following risk factors for post-operative acute kidney injury • Age ≥ 70 years...

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed) IE (Prematurely Ended)

Trial results: View results

EudraCT Number: 2014-001740-38

Sponsor Protocol Number: P130910

Start Date:

Sponsor Name: ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)

Full Title:

Medical condition:

Disease:	Version	SOC Term	Classification Code	Term	Level
	18.0	100000004851	10019515	Hemolytic uremic syndrome	LLT

Population Age: Infants and toddlers, Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: FR (Ongoing)

Trial results: (No results available)

EudraCT Number: 2020-004708-32

Sponsor Protocol Number: 232SM302

Start Date:

Sponsor Name: Biogen Idec Research Limited

Full Title: A Long-Term Extension Study of Nusinersen (BIIB058) Administered at Higher Doses in Participants With Spinal Muscular Atrophy Who Previously Participated in an Investigational Study With Nusinersen

Medical condition: Muscular Atrophy, Spinal

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.1	10010331 - Congenital, familial and genetic disorders	10041582	Spinal muscular atrophy	PT

Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults

Gender: Male, Female

Trial protocol: EE (Completed) ES (Ongoing) HU (Ongoing) DE (Ongoing) PL (Completed) IT (Ongoing) NL (Ongoing) FR (Ongoing)

Trial results: (No results available)

EudraCT Number: 2014-003346-27

Sponsor Protocol Number: ATYR1940-C-003

Start Date:

Sponsor Name: ATYR PHARMA, INC.

Full Title: An Open-Label, Intrapatient Dose-Escalation Study to Evaluate the Safety, Tolerability, Immunogenicity, and Biological Activity of ATYR1940 in Patients With Early Onset and Other Pediatric Onset Fa...

Medical condition: Early Onset and Other Pediatric Onset Facioscapulohumeral Muscular Dystrophy

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10010331 - Congenital, familial and genetic disorders	10064087	Facioscapulohumeral muscular dystrophy	PT

Population Age: Adolescents, Under 18, Adults

Gender: Male, Female

Trial protocol: IT (Prematurely Ended)

Trial results: View results

EudraCT Number: 2009-011095-30

Sponsor Protocol Number: Primo2009

Start Date:

Sponsor Name: Medizinische Fakultät Mannheim, Ruprecht-Karls-Universität Heidelberg

Full Title: Intra-individual comparison of Gd-EOB-DTPA disodium (Primovist) and Gadobutrol (Gadovist) in patients with suspicion of hepatocellular carcinoma

Medical condition: Patients of both genders are eligible for this study in case they present with suspicion of HCC after Gadovist® -enhanced MRI.

Disease:	Version	SOC Term	Classification Code	Term	Level
	12.0		10036706	Primary liver cancer non-resectable	LLT
	12.0		10036707	Primary liver cancer recurrent	LLT
	12.0		10036708	Primary liver cancer resectable	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: (No results available)

EudraCT Number: 2011-000989-35

Sponsor Protocol Number: P101001

Start Date:

Sponsor Name: ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)

Full Title:

Medical condition:

Disease:	Version	SOC Term	Classification Code	Term	Level
	14.0	10010331 - Congenital, familial and genetic disorders	10066131	Congenital central hypoventilation syndrome	PT

Population Age: Adolescents, Under 18, Adults

Gender: Female

Trial protocol: FR (Ongoing)

Trial results: (No results available)

EudraCT Number: 2005-000346-36

Sponsor Protocol Number: BPLG-004

Start Date:

Sponsor Name: BioPartners GmbH [...] 1. BioPartners GmbH 2. LG Life Science Ltd.

Full Title: A Phase III, Multi-centre, Randomised, Parallel Group Study of Safety and Efficacy of the LB03002 a New Sustained Release Formulation of Human Recombinant Growth Hormone as Compared to Standard Dai...

Medical condition: pre-pubertal drug naïve growth-deficient children with insufficient endogenous growth hormone secretion

Disease:	Version	SOC Term	Classification Code	Term	Level
			10056438		LLT

Population Age: Children, Under 18

Gender: Male, Female

Trial protocol: AT (Completed) FI (Prematurely Ended) SE (Prematurely Ended) SK (Completed) HU (Completed) CZ (Prematurely Ended) IT (Completed) DE (Completed) LT (Prematurely Ended) EE (Prematurely Ended) LV (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2008-004093-40

Sponsor Protocol Number: 08-PIR-03

Start Date:

Sponsor Name: Nektar Therapeutics

Full Title: A Multicenter, Open-Label, Randomized, Phase 2 Study to Evaluate the Efficacy and Safety of NKTR-102 (PEG-Irinotecan) Versus Irinotecan in Patients with Second-Line, Irinotecan-Naïve, KRAS-Mutant, ...

Medical condition: Refractory Solid Tumors (Colorectal Cancer) Tumores sólidos refractarios (Cáncer colorrectal)

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10061451	Colorectal cancer	LLT
	9.1		10065147	Malignant solid tumor	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: ES (Completed) BE (Prematurely Ended) DE (Completed) GB (Completed) SK (Completed) LV (Completed)

Trial results: View results

EudraCT Number: 2021-002686-18

Sponsor Protocol Number: EP0162

Start Date:

Sponsor Name: UCB Biopharma SRL

Full Title: A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Outpatient, Parallel-Group Study to Assess the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Olde...

Medical condition: Treatment of stereotypical prolonged seizure

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10029205 - Nervous system disorders	10076333	Prolonged seizure	LLT

Population Age: Adolescents, Under 18, Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Ongoing) IT (Ongoing) FR (Ongoing) HU (Ongoing) CZ (Ongoing) ES (Ongoing) PL (Ongoing) BG (Ongoing)

Trial results: (No results available)

Latest Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions